NCT06658444

Brief Summary

Cesarean section is one of the most common abdominal operations performed on women. The cesarean section rate is rising rapidly and continuously in many parts of the world. The cesarean-section surgery leaves a scar that requires special care. A horizontal skin incision approximately 10-15 cm long is usually performed during the procedure. Apart from the skin, the following: subcutaneous tissue, fascia, peritoneum, and uterine muscle are cut leaving traces in the form of scars and accompanying ailments, on the one hand, such as pain, tenderness, and hypersensitivity to stimuli, and on the other, limitations, such as contractures or impairment of tissue mobility

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 12, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 24, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 26, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

October 26, 2024

Status Verified

October 1, 2024

Enrollment Period

4 months

First QC Date

October 24, 2024

Last Update Submit

October 24, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Modified Vancouver scar scale

    Assesses four characteristics of vascularity, pigmentation, pliability, and height The larger the The larger the total score, the worse the scar . Normal skin (zero score)

    12 weeks

  • Tonometer

    Tonometer The measurement area is placed directly under the tissue tonometer. A blunt piston is pressed into the tissue by the weight, and the resulting output reading is shown. The measurements are proportional to the tissue's pliability. All measurement procedures will be explained to each woman in both groups.

    12 weeks

Study Arms (2)

phonophoresis group

EXPERIMENTAL

Twenty women will receive onion extract phonophoresis (3 sessions/week) for 12 weeks in addition to deep friction massage.

Other: Phonophoresis

control group

SHAM COMPARATOR

Twenty women will receive sham ultrasound (3 sessions/week) for 12 weeks in addition to deep friction massage.

Other: sham ultrasound

Interventions

Pulsed ultrasound will be used at a frequency of 1 MHz with an intensity of 0.5 W/ cm2 for 5 minutes.

phonophoresis group

sham ultrasound

control group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Their ages will be ≥18 years old. All women had given birth via elective abdominal transversal C-section for the first time.
  • All women suffering from Postsurgical Scar Of Cesarean-Section about 2-3 months post-surgery.
  • All women will provide an informed consent form agreeing to participate and publication of the study results

You may not qualify if:

  • Any pathological conditions or associated injuries affect the result of the study.
  • Skin disease. Cognitive and psychological impairment. Patients have implanted electronic devices, such as cardiac pacemakers, to prevent ultrasound interference.
  • Women with diabetes, cardiovascular problems, or a previous history of any disorder may alter sensation and delay the healing process which counteracts the study's goal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Heba

Cairo, Egypt

RECRUITING

Heba

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

Cicatrix

Interventions

Phonophoresis

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Drug Administration RoutesDrug TherapyTherapeutics

Study Officials

  • Heba Haridy, doctoral

    Egypt

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Heba Haridy, doctoral

CONTACT

Menna mohmed, doctoral

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Ultrasound-based therapy has proven to be a viable option for treating abnormal scarring. It has been shown to reduce the growth of keloids or postoperative scars. Phonophoresis's advantages include noninvasiveness, good compliance, low cost, and minimal gastrointestinal side effects. Onion extracts were originally used for treating full and partial-thickness burns; however, more recently these have been trialed for treating hypertrophic and keloid scarring, and healing wounds. onion extract plays the main role in reducing scar through the inhibition of fibroblast proliferation and collagen production.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer of basic science department

Study Record Dates

First Submitted

October 24, 2024

First Posted

October 26, 2024

Study Start

September 12, 2024

Primary Completion

December 30, 2024

Study Completion

January 1, 2025

Last Updated

October 26, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations